CD163 and metabolic dysfunction-associated steatotic liver disease: Indeed, in children with biopsy-proven NAFLD or NASH, a significant increase in the amount of hepatic CD163-positive cells was observed in those with severe histological activity, and in close correlation with the presence and extent of fibrosis (137).